NCT01545037 - Effect of BIO-K+ on Symptoms of Irritable Bowel Syndrome | Biotech Hunter

Enrollment

117

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions

Irritable Bowel Syndrome

Interventions

DIETARY_SUPPLEMENT

L. acidophilus CL1285® + L. casei LBC80R® + L. rhamnosus CLR2®

Each capsule contains 50 billion cfu live of Lactobacillus acidophilus CL1285® + L. casei LBC80R® + L. rhamnosus CLR2® bacterias. The randomized subjects will consume 2 capsules per day at breakfast.

OTHER

Placebo

The placebo capsules are identical in shape, taste, and smell yet are devoid of live bacteria.

Trial Locations (3)

91631

Westlake Medical Research, Westlake Village

92840

Digestive and Liver Disease Specialists A Medical Group. Inc, Garden Grove

94109

Sprim ALS, San Francisco